Daliresp (Roflumilast) — Patient-Friendly Guide (UK)

Daliresp is a prescription medicine containing roflumilast, used to help manage certain long-term lung conditions. This guide explains what Daliresp is, how it works, how to take it, and what to expect regarding safety and interactions—tailored to information relevant for the United Kingdom.

This information is written to be easy to understand and practical. Always follow the instructions given by your healthcare professional and read the package leaflet provided with your medicine.

1) Basic product information

• Medicine name: Daliresp
• Active ingredient: roflumilast
• Medicinal form: tablets
• Common strength: 250 micrograms (start dose in many patients); maintenance often 500 micrograms daily
• Medicine type: phosphodiesterase-4 (PDE4) inhibitor
• Who it’s for: adults with severe chronic obstructive pulmonary disease (COPD) who are at risk of flare-ups (exacerbations)

2) What Daliresp is used for (typical use)

Daliresp is used in adults with chronic obstructive pulmonary disease (COPD)—particularly those with a history of frequent exacerbations (flare-ups). It may also be considered in certain patients with chronic bronchitis symptoms.

Importantly, Daliresp is a maintenance treatment. It is not designed to quickly relieve sudden shortness of breath during an acute attack.

Timing and how to use it day-to-day

• Take once daily at about the same time each day.
• Your clinician may start with a lower dose (often 250 micrograms daily) for a period to improve tolerance, then increase to a typical maintenance dose (often 500 micrograms daily).
• Keep taking it regularly even if you feel better. Benefits are gradual.

3) How Daliresp works (mechanism of action)

Roflumilast works by blocking an enzyme called phosphodiesterase-4 (PDE4). PDE4 normally breaks down a messenger molecule inside cells called cyclic AMP (cAMP).

By inhibiting PDE4, roflumilast can increase cAMP levels, which helps to:

• Reduce inflammation linked to COPD in the airways
• Modulate immune responses involved in worsening breathlessness and exacerbations
• Support a lower risk of flare-ups when used as part of standard COPD therapy

Daliresp is not a bronchodilator “rescue” inhaler. It is intended to improve long-term disease control.

4) Indications (when doctors commonly prescribe it)

In the UK, Daliresp (roflumilast) is indicated for use in adults with severe COPD associated with:

• Chronic bronchitis (typically persistent cough and phlegm), and
• Frequent exacerbations (often flare-ups requiring medical treatment)

Your individual suitability depends on your COPD history, symptoms, lung function, and other treatments you already use (such as inhalers containing long-acting bronchodilators and inhaled corticosteroids).

5) Dosing — typical approach

Dosing can vary depending on tolerance, symptom control, and clinician assessment. The information below reflects common practice; always confirm your specific plan with your healthcare professional.

Common adult dosing pattern

Missed dose

• If you miss a dose, take it when you remember unless it is close to the time for your next dose.
• Do not take a double dose to make up for a missed tablet.

Stopping or switching

Do not stop Daliresp suddenly without medical advice. If you develop troublesome side effects, your clinician may adjust the dose, review your overall COPD regimen, or recommend alternative options.

6) Food interactions and taking Daliresp with meals

Roflumilast can be taken with or without food in most patients. Taking it consistently with the same routine (e.g., after breakfast) may improve adherence and tolerance.

If you experience stomach upset, nausea, or diarrhoea, you may find it easier to take it with food—however, follow the guidance you were given.

• With food: generally acceptable; may help reduce some gastrointestinal effects.
• Without food: also usually acceptable, but some people report more nausea.

7) Alcohol and medicine interactions

Alcohol

There is no universal “absolute” restriction on alcohol for all people taking roflumilast. However, alcohol can worsen:

• GI side effects (such as nausea or diarrhoea)
• sleep quality and overall health
• respiratory symptoms in some patients

If you choose to drink alcohol, consider doing so in moderation and monitor how you feel. Tell your healthcare professional if you notice worsening symptoms after alcohol.

Common medicine interaction considerations

Like many prescription medicines, roflumilast can interact with other drugs—especially those that affect liver enzymes involved in drug metabolism (notably the CYP system).

Do not start or stop any medicines (including over-the-counter products and herbal remedies) without checking compatibility. In the UK, ask your pharmacist to review your current list.

Examples of interaction patterns that may be important

• Strong enzyme inducers (medicines that speed up metabolism) may reduce roflumilast levels and effectiveness.
• Medicines that affect liver enzyme activity may change how roflumilast is processed.
• Other COPD medicines (inhalers, systemic steroids, antibiotics when needed) are commonly used together, but the full combination should be reviewed for tolerability.

Your pharmacist can provide advice based on your exact regimen (for example, long-acting bronchodilator inhalers, inhaled corticosteroids, and any treatments for asthma, depression, or other conditions).

8) Pharmacokinetics (how the body handles roflumilast)

Pharmacokinetics describes how a medicine is absorbed, distributed, metabolised, and eliminated. Understanding this helps explain why dosing is once daily and why effects build gradually.

• Absorption: After taking a tablet, roflumilast is absorbed from the gastrointestinal tract.
• Metabolism: Roflumilast is extensively metabolised in the liver, producing an active metabolite (as with many medicines in this class).
• Time to effect: Because of metabolism and ongoing inflammation modulation, clinical benefits may take days to weeks to become clear.
• Elimination: The drug and its metabolites are eliminated mainly via the kidneys and through metabolic processes.
• Half-life: The elimination profile supports once-daily dosing.

Individual factors such as liver function, smoking status, and age can influence how people respond and tolerate treatment.

9) Safety profile — common and serious side effects

As with all medicines, Daliresp may cause side effects. Some are more common at the start of treatment or after dose increases. Many improve with time or dose adjustment.

Common side effects

• Diarrhoea (may occur especially early)
• Nausea
• Abdominal discomfort
• Weight loss
• Headache
• Reduced appetite
• Insomnia or sleep disturbance

Serious side effects — seek urgent medical advice

• Severe diarrhoea or signs of dehydration (e.g., dizziness, very dry mouth, fainting)
• Marked or ongoing weight loss or signs of malnutrition
• Mood or mental health changes such as new or worsening depression, anxiety, agitation, or suicidal thoughts
• Allergic reactions (e.g., swelling of face/lips, difficulty breathing, widespread rash)

If you have a history of depression or mood disorders, discuss this with your healthcare professional before starting. If your mood changes during treatment, contact a clinician promptly.

10) Practical use tips for UK patients

Take it consistently

• Choose a daily time you can stick to (e.g., after breakfast).
• If you forget often, consider setting a daily reminder.

Manage gastrointestinal side effects

• Stay hydrated, especially if you get diarrhoea.
• Eat bland, light meals if nausea occurs.
• Inform your clinician if symptoms are persistent or severe—dose adjustment may be needed.

Monitor weight

Weight loss has been reported with roflumilast. It’s helpful to:

• Check your weight regularly (for example, weekly) while starting and after any dose increase
• Speak to your healthcare professional if weight drops significantly or appetite is reduced

Watch mental health

• Be alert to any new or worsening depression, anxiety, or unusual changes in mood or behaviour.
• Involve a trusted person if you’re concerned—early contact with a clinician matters.

Keep your COPD plan complete

Daliresp is typically used alongside standard COPD therapies, such as:

• Long-acting bronchodilator inhalers
• In some patients, inhaled corticosteroids
• Vaccinations (e.g., flu and pneumococcal) and smoking cessation support
• Pulmonary rehabilitation and action plans for exacerbations

11) Alternatives to Daliresp (roflumilast)

Depending on your COPD severity, symptoms, exacerbation history, and comorbidities, clinicians may consider other options. Alternatives may include:

Medication alternatives (examples)

• Inhaled maintenance therapies (e.g., long-acting beta-agonists, long-acting muscarinic antagonists, or combinations)
• Inhaled corticosteroids in selected patients (often for those with frequent exacerbations and specific features)
• Other add-on treatments used for certain COPD phenotypes (your clinician will decide which fits)

Non-medicine approaches

• Smoking cessation (often the most impactful step for slowing COPD progression)
• Pulmonary rehabilitation
• Vaccinations and prompt treatment of respiratory infections
• Breathing techniques and activity planning

Your best alternative depends on what problem Daliresp is intended to reduce (e.g., exacerbation risk) and how you tolerate medicines.

12) Market and legal context in the United Kingdom

In the UK, medicines such as Daliresp are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). Information about usage, warnings, and ongoing safety monitoring is communicated through official product information and UK healthcare channels.

COPD treatment strategies in the UK commonly follow recognised guidance from organisations such as:

• National Institute for Health and Care Excellence (NICE)
• Global Initiative for Chronic Obstructive Lung Disease (GOLD) (used internationally and often referenced in clinical practice)
• Local NHS COPD pathways

Availability can depend on local prescribing practice, stock in UK distribution networks, and supply continuity.

Recent guidance (high-level)

Treatment priorities in COPD continue to emphasise:

• Optimising inhaled maintenance therapy before adding second-line options
• Reducing exacerbation risk
• Addressing comorbidities (including mood disorders and nutrition/weight changes)
• Regular review of inhaler technique and adherence

Your clinician will also consider the balance of benefits versus side effects, particularly gastrointestinal tolerability, weight effects, and mental health risk considerations.

13) Delivery and availability in the UK (online pharmacy)

Daliresp availability can vary by strength and pack size. When ordering online from a UK pharmacy, availability depends on supplier stock and delivery scheduling.

• Delivery: Most UK pharmacies offer standard and express options depending on the courier network.
• Stock status: If a particular strength is temporarily unavailable, the pharmacy may show an estimated restock time or suggest an alternative equivalent where appropriate.
• Cold-chain: Daliresp tablets generally do not require refrigeration.

For best results, order early if you are approaching your next refill date. If you travel or have a busy schedule, consider arranging delivery to a time when someone can safely receive the parcel.

14) Frequently Asked Questions (FAQ)

How long does it take for Daliresp to work?

Daliresp is designed for long-term reduction in exacerbation risk. Some improvements may be noticed within weeks, but effects can take time. If you don’t feel a quick change, that doesn’t necessarily mean it isn’t working—review your progress with your healthcare professional.

Can I take Daliresp with my inhalers?

Many people take Daliresp alongside inhaled COPD treatments. However, the full combination should be reviewed to ensure it suits your specific situation and to manage side effects effectively.

What should I do if I get diarrhoea or nausea?

Mild stomach upset can improve after your body adjusts. Drink fluids and consider taking the tablet with food. If diarrhoea is severe, persistent, or you become dehydrated, contact a clinician promptly.

Will Daliresp cause weight loss?

Weight loss can occur in some patients. Monitor your weight regularly and let your healthcare professional know if you notice significant reduction in appetite or unintentional weight loss.

Is Daliresp safe if I have depression or anxiety?

Daliresp may be associated with mood changes in some people. If you have a history of depression or similar conditions, discuss this before starting and promptly report any new/worsening mood symptoms while taking it.

Can I drink alcohol while taking Daliresp?

Moderate alcohol may be possible for some people, but alcohol can worsen GI symptoms and may affect overall wellbeing. If you notice symptom worsening after drinking, reduce or avoid alcohol and speak to your healthcare professional.

What medicines should I tell my pharmacist about?

Tell your pharmacist about all medicines and supplements you take, including:

• Other COPD medicines (especially steroids)
• Medicines for depression/anxiety
• Painkillers, antibiotics, or antifungals
• Herbal products
• Any recent changes to your treatment

What if I miss a tablet?

Take it when you remember unless it is nearly time for the next dose. Do not take a double dose.

Where can I find more detailed official information?

The manufacturer’s patient leaflet included with your medicine is the most detailed source of information about specific warnings, dosing, and side effects.

Key takeaways

• Daliresp (roflumilast) helps manage severe COPD by reducing inflammation through PDE4 inhibition.
• It is used for long-term control and reducing exacerbation risk, not for immediate symptom relief.
• It’s commonly taken once daily, often starting at a lower dose to improve tolerability.
• Watch for gastrointestinal effects, weight loss, and mood changes.
• Review interactions with your pharmacist, particularly medicines affecting liver enzyme activity.

If you have specific health conditions (such as liver problems, recent weight changes, or a history of depression), talk to your healthcare professional before or shortly after starting Daliresp.